Digital Look

Welcome to Digital Look++,
you are not logged in

Scancell Holdings (SCLP)

Pharma and Biotech

9.60p

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
31-Oct-25	Interim	n/a	(6.81)	(0.55)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Apr-21	n/a	(16.81)	(2.28)p	n/a	n/a	n/a	n/a	0.0%
30-Apr-22	n/a	(6.27)	(0.56)p	n/a	n/a	n/a	n/a	0.0%
30-Apr-23	5.27	(14.30)	(1.50)p	n/a	n/a	n/a	n/a	0.0%
30-Apr-24	n/a	(9.12)	(0.68)p	n/a	n/a	n/a	n/a	0.0%
30-Apr-25	4.71	(15.30)	(1.26)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.